IMCR logo

IMCR Immunocore Holdings plc

NASDAQ Global Select · Biotechnology · Healthcare

$27.38
-0.13 (-0.47%)

Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatmen…

Market Cap: $1.41Bwww.immunocore.com

Price

No data yet.

Social Signal Score

52
5d
—
30d
50
4 mentions
—
60d
50
5 mentions
—
90d
55
9 mentions
—
news: 9

Analyst Ratings

14 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 5Sell 0Strong Sell 0
Avg price target$39+42.4%
Low $35Median $39High $43
Current Consensus

Revenue

$102.22M+1316.75%
$5.61M$42.38M$79.15M$115.93M
Mar 2019Sep 2026

Analyst Estimates

FY2025
$-0.32
$-0.73–$-0.11
9 analysts
FY2026
$-0.23
$-0.42–$-0.06
8 analysts
FY2027
$-0.48
$-22.20–$31.98
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Bahija Jallal
Sector
Healthcare
Industry
Biotechnology
Employees
524
Beta
0.81
Country
GB
Piotroski score
2 / 9 (Weak)
Altman Z-score
1.13
www.immunocore.com